Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Camden National
CAC
$968M
| $46.7M | 0.01% |
862,045
+31,695
| +4% | +$1.59M |
|
1627
Metropolitan Bank Holding Corp
MCB
$1.11B
| $46.7M | 0.01% |
472,599
+12,808
| +3% | +$1.16M |
|
1628
British American Tobacco
BTI
$121B
| $46.5M | 0.01% |
753,029
-9,756
| -1% | -$589K |
|
1629
Amphastar Pharmaceuticals
AMPH
$1.02B
| $46.5M | 0.01% |
2,305,107
+277,160
| +14% | +$5.59M |
|
1630
Atlanticus Holdings
ATLC
$1.42B
| $46.5M | 0.01% |
454,394
-68,151
| -13% | -$5.53M |
|
1631
Marcus & Millichap
MMI
$1.18B
| $46.4M | 0.01% |
1,489,218
+7,446
| +0.5% | +$213K |
|
|
GRAL
1632
GRAIL Inc
GRAL
$3.47B
| $46.4M | 0.01% |
679,587
+270,937
| +66% | +$16M |
|
|
GOLD
1633
Gold.com Inc
GOLD
$1.4B
| $46.4M | 0.01% |
1,114,243
+25,489
| +2% | +$1.1M |
|
1634
Agios Pharmaceuticals
AGIO
$2.03B
| $46.3M | 0.01% |
1,248,738
+97,124
| +8% | +$2.95M |
|
1635
Edgewise Therapeutics
EWTX
$5.13B
| $46.3M | 0.01% |
1,139,726
-79,991
| -7% | -$2.76M |
|
1636
Cimpress
CMPR
$1.98B
| $46.2M | 0.01% |
454,746
+7,810
| +2% | +$694K |
|
1637
Tootsie Roll Industries
TR
$2.83B
| $46.2M | 0.01% |
1,168,746
+16,032
| +1% | +$649K |
|
1638
Algonquin Power & Utilities
AQN
$4.11B
| $46.1M | 0.01% |
7,868,948
+152,052
| +2% | +$923K |
|
1639
BridgeBio Pharma
BBIO
$13.5B
| $46.1M | 0.01% |
619,126
+57,181
| +10% | +$4.01M |
|
1640
Gerdau
GGB
$9.77B
| $46.1M | 0.01% |
11,394,004
-481,627
| -4% | -$2.14M |
|
1641
LGI Homes
LGIH
$1.16B
| $46.1M | 0.01% |
723,490
-359,304
| -33% | -$17.2M |
|
|
PRSU
1642
Pursuit Attractions and Hospitality Inc
PRSU
$1.34B
| $46M | 0.01% |
822,681
+106,098
| +15% | +$4.69M |
|
1643
Applied Optoelectronics
AAOI
$8.64B
| $45.9M | 0.01% |
309,932
+38
| +0% | +$6.18K |
|
1644
Stagwell
STGW
$2.06B
| $45.8M | 0.01% |
6,170,065
+1,134,745
| +23% | +$7.52M |
|
1645
Highwoods Properties
HIW
$3.41B
| $45.7M | 0.01% |
1,514,977
-36,919
| -2% | -$955K |
|
1646
Shoals Technologies Group
SHLS
$1.22B
| $45.4M | 0.01% |
4,590,497
+321,703
| +8% | +$2.92M |
|
1647
IDT Corp
IDT
$1.72B
| $45.4M | 0.01% |
779,838
-8,209
| -1% | -$434K |
|
1648
Northeast Bank
NBN
$1.17B
| $45.3M | 0.01% |
341,886
+8,605
| +3% | +$1.06M |
|
1649
Virtus Investment Partners
VRTS
$879M
| $45.3M | 0.01% |
315,715
+10,600
| +3% | +$1.5M |
|
1650
Kyndryl
KD
$2.83B
| $45.3M | 0.01% |
4,005,704
-644,107
| -14% | -$8.03M |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.